Ozempic, Wegovy are getting generics as low as $15 around the world — what it means for Americans

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...
MedPage Today on MSN

High-Dose Wegovy Wins FDA Approval

7.2-mg injectable approved for patients who couldn't lose enough weight on the 2.4-mg dose ...

FDA approves higher-dose Wegovy shots after accelerated review

The approval was granted 54 days after the request for review was approved, the agency said in a statement. The new dosage will be available in April at pharmacies in the U.S., with a price to be ...
Healio

FDA approves high-dose Wegovy 7.2 mg for adults with obesity

The FDA approved a higher 7.2 mg dose of injectable semaglutide for adults with overweight and obesity, Novo Nordisk announced. Once-weekly injectable semaglutide 7.2 mg (Wegovy HD, Novo Nordisk) ...

FDA approves higher dose of Wegovy

The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg.
ScienceAlert on MSN

Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds

(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...
Blockonomi

Novo Nordisk (NVO) Stock — Higher-Dose Wegovy Cleared by FDA to Counter Eli Lilly Competition

FDA approves higher 7.2mg Wegovy dose for Novo Nordisk (NVO), showing 20.7% weight loss. April launch aims to challenge Eli Lilly's Zepbound dominance.

This biotech is working on a GLP-1 pill that could be better than the Wegovy version

This experimental pill helped people lose about 16% of their body weight after about a year of treatment ...